What is the recommended administration of mephentermine in infants with hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Administration of Mephentermine in Infants with Hypotension

There is insufficient evidence to recommend mephentermine for routine use in infants with hypotension. Dopamine (2-20 mcg/kg/min) is the preferred vasopressor for management of hypotension in infants when fluid resuscitation is inadequate.

Current Evidence on Vasopressors in Infants

  • The American Academy of Pediatrics and other major pediatric guidelines do not specifically recommend mephentermine for management of hypotension in infants 1
  • For hypotension refractory to volume replacement and epinephrine injections in pediatric patients, dopamine is the recommended first-line vasopressor at 2-20 mcg/kg/min 2, 1
  • Dopamine should be prepared using the "rule of 6": 0.6 × body weight (kg) = number of milligrams diluted to total 100 mL of saline; then 1 mL/h delivers 0.1 mcg/kg/min 2, 1

Monitoring During Vasopressor Administration

  • Continuous hemodynamic monitoring is essential during vasopressor administration in infants 2
  • Blood pressure should be monitored continuously, preferably with an arterial line 2
  • Extreme caution must be exercised to avoid accidental flushing/bolus injection of the IV line 2
  • Watch for extravasation which can cause severe tissue injury; phentolamine (0.1-0.2 mg/kg) can be injected intradermally at extravasation site as a countermeasure 2

Alternative Vasopressors for Infants

  • In cases where dopamine is ineffective, epinephrine (0.1-1.0 mcg/kg/min) may be considered 3, 1
  • For infants with marked circulatory instability and decompensated shock, epinephrine may be preferable to dopamine 2
  • In preterm infants with refractory hypotension, a "stress dose" of hydrocortisone (1 mg/kg every 8 hours) has shown effectiveness when vasopressors are inadequate 4

Special Considerations in Neonates

  • Preterm infants require a more cautious approach to volume resuscitation and vasopressor therapy compared to term neonates and children 1
  • Low birth weight infants with early systemic hypotension (<24 hours of life) may respond to either dopamine (2.5-10 mcg/kg/min) or epinephrine (0.125-0.5 mcg/kg/min) 3
  • The use of vasopressors in extremely preterm infants has been associated with higher risk of severe intraventricular hemorrhage, requiring careful consideration of risks and benefits 5

Defining Hypotension in Infants

  • Hypotension is defined by age-specific parameters 1:
    • Term neonates (0-28 days): Systolic BP <60 mmHg
    • Infants (1-12 months): Systolic BP <70 mmHg
    • Children (>1 year to 10 years): Systolic BP <70 + (2 × age in years) mmHg

Important Cautions

  • While mephentermine has been studied in adults for management of hypotension during spinal anesthesia 6, 7, there is insufficient evidence for its safety and efficacy in infants
  • Bottle, burette, or syringe pump containing vasopressors should be covered with protective foil to avoid breakdown by light 1
  • In infants with underlying cardiac dysfunction and/or signs of volume overload, additional fluid boluses should be avoided to prevent pulmonary edema 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.